To determine if upregulation of Acer3 affected ceramide metabolism in NASH liver, we measured the levels of ceramides in liver tissues collected from the above mice by LC–MS/MS analysis. Here, ACER3 is linked to metabolic dysfunction-associated steatohepatitis.